Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 39 member 14 (SLC39A14; also known as ZIP14) is a **metal ion transporter** in the ZIP family, primarily facilitating the uptake of zinc, manganese, iron, and cadmium into cells[2][3]. SLC39A14 is widely expressed, including in liver, pancreas, muscle, adipose tissue, and the brain[2][3][7]. It helps maintain systemic and cellular metal ion homeostasis and plays essential roles in **regulating glucose metabolism, insulin secretion, immune signaling, and systemic growth**[1][2][4][5]. ZIP14 is upregulated during inflammation and is involved in the body's acute-phase response, modulating signaling pathways such as GPCR-mediated cAMP generation, NF-κB, and STAT3[4][5][6]. Germline mutations in SLC39A14 can cause **hereditary manganese accumulation and neurotoxicity**, while its dysregulation influences susceptibility to metabolic inflammation, obesity, and cachexia[3][5][7]. As a transporter, SLC39A14 is a potential therapeutic target in disorders of metal ion metabolism and related systemic diseases.
Not applicable for approved drugs; mechanisms studied involve alteration of metal transport to modulate intracellular zinc, iron, or manganese levels that impact signaling pathways (e.g., GPCR-cAMP-CREB pathway, inhibition of phosphodiesterases, modulation of insulin signaling)[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 39 member 14 (SLC39A14).